• About Us
  • Who Are We
  • Work With Us
Friday, March 31, 2023
No Result
View All Result
NEWSLETTER
The Globe Post
39 °f
New York
44 ° Fri
46 ° Sat
40 ° Sun
41 ° Mon
No Result
View All Result
The Globe Post
No Result
View All Result
Home World

In World First, Polish Pharmaceutical Company Produces Plasma-Derived COVID Drug

Anya Ruppert by Anya Ruppert
08/18/20
in World
In World First, Polish Pharmaceutical Company Produces Plasma-Derived COVID Drug

Biomed Lublin launches production of COVID-19 cure. Photo: AFP

Share on FacebookShare on Twitter

Polish pharmaceutical company Biomed Lublin has started producing a coronavirus drug from human plasma with COVID-19 antibodies.

“From today, it will be about two months until the release of the anti-SARS-CoV-2 immunoglobulin [antibodies] for clinical trials,” Biomed management board member Piotr Fic said at a press conference at the medical university in Lublin in eastern Poland. “We will be able to release the drug for clinical trials, probably by the end of October.”

In late July, the company planned to collect more than 80 liters of plasma from nine regional blood donation centers. Now, a total of 150 liters have been collected to begin production.

The production of the first batch of the first in the world #medicine for #COVID19 began on Tuesday, @BiomedLublin, the #pharmaceutical company based in #Lublin, eastern #Poland, announced.
More:https://t.co/XhYMa3djNt pic.twitter.com/gEUxjH4QYy

— Poland In (@Polandin_com) August 18, 2020

According to The American Journal of Pathology, several case studies have found the “administration of convalescent plasma as a safe treatment option for those with severe COVID-19 disease.”

Importantly, the severity of the coronavirus pandemic has allowed the drug registration procedure to take place in 150 days instead of the standard 210 days.

Co-financed by Poland’s Medical Research Agency, the drug will be tested by the Institute of Haematology and Transfusion Medicine in the country’s capital.

Biomed prepares to produce 3,000 doses that will be distributed to the Independent Public Clinical Hospital in Lublin, where clinical trials lasting four months will be overseen. After that, the company hopes to produce between 30,000 and 40,000 doses, depending on having sufficient plasma available.

ShareTweet
Anya Ruppert

Anya Ruppert

Related Posts

A woman undergoing COVID test in China
Featured

Soaring Covid Cases Shine Light on China’s Healthcare Gap

by Staff Writer
January 11, 2023
European Medicines Agency
World

EU Watchdog Approves Second Covid Booster for Over 80s

by Staff Writer
April 6, 2022
WHO
World

WHO Urges Rich Countries to Pay Up for Covid Plan

by Staff Writer
February 9, 2022
Poland border wall
Refugees

Poland Begins Work on New EU-Belarus Border Wall

by Staff Writer
January 25, 2022
Mask making
National

US Sets Global Record of Over 1 Mn Daily Covid-19 Cases

by Staff Writer
January 4, 2022
Israel Covid vaccine
World

Israel ‘Leads the Way’ With 4th Covid Jabs for Vulnerable

by Staff Writer
December 31, 2021
Next Post
Malian president Ibrahim Boubacar Keita, arriving at the airport in Ouagadougou in Burkina Faso on March 1, 2019.

Mali Coup Leaders Pledge New Elections After Detaining President

Protestors in Minsk rally against the government of President Alexander Lukashenko

'We Stand With Peaceful Demonstrators:' EU Rejects Belarus Election Result

Please login to join discussion

Recommended

Damage from a series of powerful storms and at least one tornado is seen on March 25, 2023, in Rolling Fork, Mississippi

After Tornado Kills 25, Mississippi Faces More Extreme Weather

March 26, 2023
Transgender Army veteran Tanya Walker speaks to protesters in Times Square near a military recruitment centre

Tennessee Is A Drag on the First Amendment

March 26, 2023
participants of an artificial intelligence conference

How AI Could Upend the World Even More Than Electricity or the Internet

March 19, 2023
Chinese President Xi Jinping

China’s Path to Economic Dominance

March 15, 2023
Heavily armed police inspect the area near a Jehovah's Witness church where several people have been killed in a shooting in Hamburg, northern Germany

Eight Dead in Shooting at Jehovah’s Witness Hall in Germany

March 10, 2023
Myanmar Rohingya refugees look on in a refugee camp in Teknaf, in Bangladesh's Cox's Bazar, on November 26, 2016

US Announces $26M in New Aid for Rohingya

March 8, 2023

Opinion

Transgender Army veteran Tanya Walker speaks to protesters in Times Square near a military recruitment centre

Tennessee Is A Drag on the First Amendment

March 26, 2023
Chinese President Xi Jinping

China’s Path to Economic Dominance

March 15, 2023
An earthquake survivor reacts as rescuers look for victims and other survivors in Hatay, a Turkish province where hundreds of buildings were destroyed by the earthquake

Heed the Call of Our Broken World

March 1, 2023
Top view of the US House of Representatives

‘Cringy Awards:’ Who Is the Most Embarrassing US House Representative?

February 13, 2023
Protesters rally against the fatal police assault of Tyre Nichols, outside of the Coleman A. Young Municipal Center in Detroit, Michigan, on January 27, 2023

How Do Violent ‘Monsters’ Take Root?

February 3, 2023
George Santos from the 3rd Congressional district of New York

George Santos for Speaker!

January 16, 2023
Facebook Twitter

Newsletter

Do you like our reporting?
SUBSCRIBE

About Us

The Globe Post

The Globe Post is part of Globe Post Media, a U.S. digital news organization that is publishing the world's best targeted news sites.

submit oped

© 2018 The Globe Post

No Result
View All Result
  • National
  • World
  • Business
  • Interviews
  • Lifestyle
  • Democracy at Risk
    • Media Freedom
  • Opinion
    • Editorials
    • Columns
    • Book Reviews
    • Stage
  • Submit Op-ed

© 2018 The Globe Post